Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gardasil Vaccine”

86 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 86 results

Testing effectiveness (Phase 2)Study completedNCT01461993
What this trial is testing

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17

Who this might be right for
VaccinesMeningococcal Vaccines
Pfizer 2,499
Not applicableActive Not RecruitingNCT06197802
What this trial is testing

Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women

Who this might be right for
Cervical CancerCondylomata Acuminata
Xiamen University 392
Post-approval studies (Phase 4)Active Not RecruitingNCT03943875
What this trial is testing

GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose

Who this might be right for
ImmunizationEfficacyHuman Papilloma Virus
The University of Texas Medical Branch, Galveston 767
Large-scale testing (Phase 3)Study completedNCT01304498
What this trial is testing

Immunogenicity and Tolerability of V503 Versus GARDASIL (V503-009)

Who this might be right for
Human Papillomavirus
Merck Sharp & Dohme LLC 600
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07339163
What this trial is testing

Efficacy of Booster Injection With Gardasil-9 Vaccine on Intersurgical Interval* for Adults With Recurrent Respiratory Papillomatosis*

Who this might be right for
Recurrent Respiratory Papillomatosis (RRP)
Ohio State University 50
Large-scale testing (Phase 3)Study completedNCT03546842
What this trial is testing

Safety and Immunogenicity Study of V503 (GARDASIL™9, 9vHPV Vaccine) Administered to 9- to 26-Year-Old Females and Males in Vietnam (V503-017)

Who this might be right for
Papillomavirus InfectionsUterine Cervical NeoplasmsVulvar Neoplasms+3 more
Merck Sharp & Dohme LLC 201
Large-scale testing (Phase 3)UnknownNCT05668572
What this trial is testing

A Phase III Trial Evaluates the Efficacy, Immunogenicity and Safety Profile of HPV Vaccine

Who this might be right for
Human Papillomavirus Infection
Beijing Health Guard Biotechnology, Inc 12,000
Early research (Phase 1)Study completedNCT00851643
What this trial is testing

Broad Spectrum HPV Vaccine Dose Escalation Study (V502-002)

Who this might be right for
Human Papilloma VirusCervical CancerVulvar Cancer+2 more
Merck Sharp & Dohme LLC 158
Large-scale testing (Phase 3)Study completedNCT03728881
What this trial is testing

Single Dose of Cervarix Vaccine in Girls or Three Doses of Gardasil Vaccine in Women for the Prevention of Human Papillomavirus Infection, the PRIMAVERA-ESCUDDO Trial

Who this might be right for
Human Papillomavirus-Related Cervical Carcinoma
National Cancer Institute (NCI) 1,240
Post-approval studies (Phase 4)Study completedNCT01914367
What this trial is testing

Study of the Molecular Mechanisms Underlying the Cross-neutralizing Capacity of AS04-adjuvanted HPV Vaccine (Cervarix®) in Comparison With the Aluminiumhydroxyphosphate Sulphate Adjuvanted HPV Vaccine (Gardasil®)

Who this might be right for
Infection With Human Papillomavirus
University Hospital, Ghent 12
Large-scale testing (Phase 3)Study completedNCT04782895
What this trial is testing

Immunogenicity of a Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58)Vaccine(E.Coli) Versus Gardasil®9 in Healthy Females 18-26 Years of Age

Who this might be right for
Cervical CancerCondylomata Acuminata
Xiamen University 488
Not applicableStudy completedNCT00524745
What this trial is testing

Immunogenicity and Reactogenicity of Alternative Schedules of Gardasil

Who this might be right for
Dose Schedule Study
PATH 903
Large-scale testing (Phase 3)Study completedNCT00423046
What this trial is testing

Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age

Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 1,106
Post-approval studies (Phase 4)Active Not RecruitingNCT05557370
What this trial is testing

Immunogenicity of HPV Vaccine in Transplant Recipients.

Who this might be right for
Chronic Kidney DiseasesKidney Transplant
Medical College of Wisconsin 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT03947775
What this trial is testing

HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSIL

Who this might be right for
Anal Intraepithelial NeoplasiaAnal CancerHuman Papilloma Virus
University Health Network, Toronto 228
Post-approval studies (Phase 4)Study completedNCT01424644
What this trial is testing

A Phase 4, Placebo-Controlled, Randomized Study to Evaluate the Immunogenicity and Safety of HPV and Tdap When Administered With MenACWY in Adolescents

Who this might be right for
Meningococcal Meningitis
Novartis 801
Testing effectiveness (Phase 2)Study completedNCT00260039
What this trial is testing

Broad Spectrum HPV Vaccine Dose Ranging Study (V502-001)

Who this might be right for
HPVCervical CancerPremalignancy Anogenital Warts
Merck Sharp & Dohme LLC 680
Testing effectiveness (Phase 2)Looking for participantsNCT06624839
What this trial is testing

Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV

Who this might be right for
Human Papilloma VirusAnal DysplasiaHIV
University of Maryland, Baltimore 120
Testing effectiveness (Phase 2)Study completedNCT01432574
What this trial is testing

Study of Gardasil in Mid-Adult Males (MAM)

Who this might be right for
Human Papillomavirus
H. Lee Moffitt Cancer Center and Research Institute 150
Large-scale testing (Phase 3)Study completedNCT01456715
What this trial is testing

Immunogenicity of Gardasil and Twinrix and the Effect of a Dose of Gardasil or Cervarix Given 42 Months Later.

Who this might be right for
Human Papillomavirus
Laval University 418
Load More Results